Arthritis Clinical Trials in North Carolina

51 recruiting studies across 2 cities

Browse by City

All Trials in North Carolina

Phase

Trial	Phase	Sponsor	Dist.
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis	Phase 3	Medipost, Inc.	<1 mi
A Study of Dotinurad Versus Allopurinol in Participants With Gout	Phase 3	Crystalys Therapeutics	<1 mi
Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants with Rheumatoid Arthritis with Inadequate Response or Intolerance to a DMARD Starting a New BDMARD or TsDMARD Treatment +/- CsDMARD	—	Aqtual, Inc.	<1 mi
Clinical Outcomes Study of the Nexel Total Elbow	N/A	Zimmer Biomet	<1 mi
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)	Phase 3	Amgen	<1 mi
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)	—	Zimmer Biomet	<1 mi
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis	Phase 3	Janssen Research & Development, LLC	<1 mi
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)	Phase 2	Elevara Medicines Limited	<1 mi
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis	Phase 2	AbbVie	<1 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines	Phase 3	Takeda	<1 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry	—	Duke University	<1 mi
Z1 Hip System: Post-Market Clinical Follow Up Study	—	Zimmer Biomet	<1 mi
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis	Phase 2	Janssen Research & Development, LLC	<1 mi
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).	Phase 1	Novartis Pharmaceuticals	<1 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response	Phase 3	MoonLake Immunotherapeutics AG	<1 mi
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.	Phase 2	Artiva Biotherapeutics, Inc.	<1 mi
Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)	Phase 2	Merck Sharp & Dohme LLC	<1 mi
Primary Subtalar Arthrodesis for Calcaneal Fractures	N/A	Wake Forest University Health Sciences	<1 mi
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.	Phase 3	AbbVie	<1 mi
Embo Registry; National Registry for Artery Embolization	—	Vascular Solutions of North Carolina	8 mi
Drug-Drug Interaction Study of ABP-671 in Gout Patients	Phase 1	Atom Therapeutics Co., Ltd	8 mi
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System	N/A	DT MedTech, LLC	11 mi
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications	—	AbbVie	11 mi
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))	N/A	DePuy Orthopaedics	20 mi
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis	Phase 2	Avalyn Pharma Inc.	21 mi
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)	Phase 1	UCB Biopharma SRL	21 mi
Implementing a Group Physical Therapy Program for Veterans (GroupPT): Function QUERI 3.0	N/A	VA Office of Research and Development	21 mi
Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis	N/A	Duke University	21 mi
Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only	—	Exactech	21 mi
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study	N/A	Zimmer Biomet	21 mi
Exactech Shoulder Post Market Clinical Follow-up Study	—	Exactech	21 mi
Improving Hypertension Control in Rheumatoid Arthritis	N/A	Duke University	21 mi
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic	—	Sonoma Biotherapeutics, Inc.	21 mi
Evaluating Hemidiaphragmatic Paralysis With Prolonged Neural Blockade From an Interscalene Brachial Plexus Block	—	Duke University	21 mi
Maternal Autoimmune Disease Research Alliance (MADRA) Registry	—	Duke University	21 mi
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases	Phase 1	Juno Therapeutics, Inc., a Bristol-Myers Squibb Company	21 mi
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults	Phase 1	UCB Biopharma SRL	23 mi
The Osteoarthritis Prevention Study	N/A	Wake Forest University	25 mi
Knee Biofeedback Rehabilitation Through Game Therapy	N/A	Barron Associates, Inc.	25 mi
Addressing Neuromuscular Deficits for Improved Outcomes in Ankle Rehabilitation	N/A	Phillip Gribble	25 mi
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury	N/A	University of North Carolina, Chapel Hill	25 mi
Preventing Injured Knees From osteoArthritis: Severity Outcomes	Phase 2	Brigham and Women's Hospital	25 mi
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab	Phase 3	AbbVie	25 mi
Gait Rehabilitation to Treat FastOA	N/A	University of North Carolina, Chapel Hill	25 mi
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.	Phase 1	AstraZeneca	25 mi
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)	Phase 1	Juno Therapeutics, Inc., a Bristol-Myers Squibb Company	25 mi
A Study of AZD0120 in Autoimmune Diseases	Phase 1	AstraZeneca	25 mi
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)	Phase 4	Eli Lilly and Company	37 mi
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain	Phase 3	Novo Nordisk A/S	39 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee	Phase 3	Eli Lilly and Company	39 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines	Phase 3	Takeda	45 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.